CFTC orders Trafigura to pay $55M over fraud, impeding whistleblowers
By 
Aaron Nicodemus2024-06-17T20:35:00
Singapore-based commodity trading company Trafigura will pay $55 million to the Commodity Futures Trading Commission (CFTC) to settle charges related to fraud, manipulation, and impeding whistleblower communications with the agency.
Trafigura used material nonpublic information from an employee of a Mexican trading company its traders knew or were reckless in not knowing, the CFTC alleged in a press release Monday.
In February 2017, the company manipulated a fuel oil benchmark to benefit its futures and swaps positions and violated the Mexican employee’s duties to the trading entity where they worked, the agency added.
Related articles
-
News BriefSEC fines Nationwide Planning, affiliates combined $240K over impeding whistleblowers
Broker-dealer Nationwide Planning Associates and two affiliated investment advisers impeded potential whistleblowers from reporting misconduct to the Securities and Exchange Commission and have agreed to settle the charges for a combined $240,000.
-
News BriefCFTC, ICE Futures fine Brazil-based Raizen Energia $850K over wash trading
Brazilian energy and sugar company Raizen Energia SA and its Swiss trading subsidiary will pay $850,000 in fines to settle charges that they engaged in illegal noncompetitive transactions.
-
News BriefCiti unit fined $78.6M by U.K. regs for trading control failures
The Financial Conduct Authority and Prudential Regulation Authority combined to fine a London-based Citigroup subsidiary approximately £61.7 million (U.S. $78.6 million) for control failures related to its trading system.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”